Dyslipidemia News and Research

RSS

Dyslipidemia is a disruption in the amount of lipids in the blood.

Researchers discover how intestinal bacteria can influence blood glucose and lipid concentrations

Intestinal bacteria have attracted recent attention since they were discovered to influence various physiological functions and diseases in humans.

10 Apr 2018

Thrill of hockey victory may raise heart attack risk in younger men

The thrill of a hockey victory may put younger men at an increased risk for heart attack. A new study published in the Canadian Journal of Cardiology found an increase in hospital admissions for men under 55 presenting with symptoms of ST-elevation myocardial infarction or heart attack the day after a Montreal Canadiens win.

29 Mar 2018

Breastfeeding linked to lower risk of hypertension

A study published in the American Journal of Hypertension indicates that women who breastfeed more children, and for longer periods of time, are less likely to suffer from hypertension after they reach menopause.

30 Jan 2018

Obese adolescents show improvements in cardiovascular disease risk factors after bariatric surgery

Adolescents with severe obesity who had bariatric surgery showed significant improvements in cardiovascular disease risk factors, according to the most recent "Teen Longitudinal Assessment of Bariatric Surgery" (Teen-LABS) study, published online today by Pediatrics.

8 Jan 2018

Study reveals link of male-pattern baldness and premature graying with early heart disease

New research presented at the 69th Annual Conference of the Cardiological Society of India (CSI) indicated that premature greying and male-pattern baldness are linked to a greater than fivefold risk of heart disease before the age of 40. The study also suggested obesity is linked to a fourfold risk of early heart disease.

30 Nov 2017

Study highlights need to improve quality of cardiovascular care for HIV-positive adults

People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV. The researchers believe this to be the first national study comparing statin use in patients with and without HIV and the first extensive analysis using U.S. data.

23 Nov 2017

New studies highlight importance of cardiorespiratory fitness to reduce CVD risk

Coronary heart disease (CHD) is a leading cause of death for men in the U.S. Both cardiorespiratory fitness (CRF) and the blood triglyceride/high-density lipoprotein ratio (TG:HDL ratio) are strong predictors of death from CHD. In the current issue of Mayo Clinic Proceedings, two new studies highlight the importance of CRF on subsequent CVD and mortality risk.

17 Nov 2017

Caffeine consumption may prolong lives of kidney disease patients

Caffeine consumption may prolong the lives in patients with chronic kidney disease (CKD), according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.

3 Nov 2017

Asian dust exposure associated with onset of myocardial infarction

A recent environmental epidemiological study by Japanese researchers has shown that Asian sand particles blown to Japan from desert areas of the Asian continent are associated with the onset of myocardial infarction.

11 Sep 2017

Studies aim to better understand potential health benefits of red raspberries

Initial findings from several studies - including both human subjects and animals - on the potential health benefits of red raspberries were presented earlier this year at the 2017 Experimental Biology conference in Chicago.

24 Aug 2017

High level of heart disease pipeline innovation could bridge unmet need in treating CVD

With over 1,400 products in active development, the innovation pipeline for cardiovascular disease (CVD) is extensive, with four key CVD indications – hypertension, heart failure, dyslipidemia and thrombosis – now accounting for around half of all pipeline innovation, according to GBI Research, a recognized leader in providing business information and analytics.

24 Aug 2017

Study: Liver inflammation increases cholesterol levels in people with diabetes

Inflammatory processes in the liver lead to elevated cholesterol levels in people with diabetes, thus promoting subsequent vascular diseases. This is the result of a study by scientists of Helmholtz Zentrum München, Technische Universität München and the Collaborative Research Center SFB 1118 at Heidelberg University Hospital.

14 Aug 2017

Research shows alarming prevalence of overfat pandemic in developed countries

Does your waist measure more than half your height? If so, you may be part of the global overfat pandemic.

24 Jul 2017

Brown fat in humans: more than previously thought

Brown fat is a tissue well studied in small mammals, where it acts as a heat-producing organ to stay warm in a cold environment. Its unequivocal identification in adult, healthy humans about a decade ago is of major importance due to its immense capacity to convert chemical energy into heat

20 Apr 2017

Metabolic syndrome is the new 'silent killer', warn researchers

For decades, American waistlines have been expanding and there is increasing cause for alarm. Researchers from the Charles E. Schmidt College of Medicine at Florida Atlantic University make the case that metabolic syndrome -- a cluster of three of more risk factors that include abdominal obesity, high triglycerides, high blood pressure, abnormal lipids, and insulin resistance, a precursor of type 2 diabetes -- is the new "silent killer," analogous to hypertension in the 1970s.

6 Apr 2017

High levels of thyroid hormone linked to more weight loss after bariatric surgery

Patients who have higher levels of the thyroid hormone triiodothyronine (T3) lose more weight after bariatric surgery, new research from Portugal reports.

4 Apr 2017

Research shows pNaKtide can attenuate development of NAFLD and atherosclerosis

Building on their recent research focusing on a peptide, pNaKtide, designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers at Marshall University Joan C. Edwards School of Medicine have successfully demonstrated that pNaKtide, can attenuate the development of experimental nonalcoholic fatty liver disease (NAFLD) and atherosclerosis.

15 Mar 2017